Cargando…
Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
In-depth analyses of cancer cell proteomes are needed to elucidate oncogenic pathomechanisms, as well as to identify potential drug targets and diagnostic biomarkers. However, methods for quantitative proteomic characterization of patient-derived tumors and in particular their cellular subpopulation...
Autores principales: | Bohnenberger, Hanibal, Ströbel, Philipp, Mohr, Sebastian, Corso, Jasmin, Berg, Tobias, Urlaub, Henning, Lenz, Christof, Serve, Hubert, Oellerich, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MyJove Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4401153/ https://www.ncbi.nlm.nih.gov/pubmed/25867170 http://dx.doi.org/10.3791/52435 |
Ejemplares similares
-
Quantitative proteomics identifies biomarkers to distinguish pulmonary from head and neck squamous cell carcinomas by immunohistochemistry
por: Richter, Annika, et al.
Publicado: (2021) -
Proteomic Comparison of Malignant Human Germ Cell Tumor Cell Lines
por: Bremmer, Felix, et al.
Publicado: (2019) -
Proteomic mapping of atrial and ventricular heart tissue in patients with aortic valve stenosis
por: Barbarics, Boris, et al.
Publicado: (2021) -
Recent advances and conceptual changes in the classification of neuroendocrine tumors of the thymus
por: Bohnenberger, Hanibal, et al.
Publicado: (2021) -
Activation of CD44/PAK1/AKT signaling promotes resistance to FGFR1 inhibition in squamous-cell lung cancer
por: Elakad, Omar, et al.
Publicado: (2022)